3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages
2026-03-05 13:35:00 ET
Earth's human population is aging. According to recent research from the World Health Organization, from 2015 to 2050, the proportion of people 60 or older will almost double, from 12% of the total to 22%.
That's a big leap over a relatively short period, and the trend offers a significant opportunity for medical device makers , especially Boston Scientific (NYSE: BSX) . Here are three reasons why its stock can quintuple -- at least -- on the back of this shift.
Boston Scientific's focus on afflictions that affect older patients is nothing new. Its Watchman line, which debuted in 2015, consists of small balloon-expandable heart inserts that reduce stroke risk in those with a type of atrial fibrillation (a disorder that skews toward the elderly).
NASDAQ: BSX
BSX Trading
-1.05% G/L:
$68.37 Last:
2,821,634 Volume:
$69.63 Open:
